E
Emma Horner-Glister
Researcher at University of Leicester
Publications - 8
Citations - 439
Emma Horner-Glister is an academic researcher from University of Leicester. The author has contributed to research in topics: Autophagy & Resveratrol. The author has an hindex of 6, co-authored 8 publications receiving 382 citations. Previous affiliations of Emma Horner-Glister include Leicester Royal Infirmary.
Papers
More filters
Journal ArticleDOI
Sulfate Metabolites Provide an Intracellular Pool for Resveratrol Generation and Induce Autophagy with Senescence
Ketan R. Patel,Catherine Andreadi,Robert G. Britton,Emma Horner-Glister,Ankur Karmokar,Stewart Sale,Victoria A. Brown,Dean E. Brenner,Rajinder Singh,William P. Steward,Andreas J. Gescher,Karen Brown +11 more
TL;DR: The findings suggest that resveratrol is delivered to target tissues in a stable sulfate-conjugated form and that the parent compound is gradually regenerated in selected cells and may give rise to the beneficial effects in vivo.
Journal ArticleDOI
Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice
Hong Cai,Edwina N. Scott,Abeer O. Kholghi,Catherine Andreadi,Alessandro Rufini,Ankur Karmokar,Robert G. Britton,Emma Horner-Glister,Peter Greaves,Dhafer Jawad,Mark I. James,Lynne M. Howells,Ted J. Ognibene,Michael A. Malfatti,Christopher E. Goldring,Neil R. Kitteringham,Joanne Walsh,Maria Viskaduraki,Kevin West,Andrew S. Miller,David Hemingway,William P. Steward,Andreas J. Gescher,Karen Brown +23 more
TL;DR: It is shown that a low rather than a high dose of resveratrol prevents tumor growth in mice and alters metabolic pathways in human tissues and suggests that it's time for a revision in development strategies for preventative dietary agents.
Journal ArticleDOI
Synthesis and biological evaluation of novel flavonols as potential anti-prostate cancer agents.
Robert G. Britton,Emma Horner-Glister,Odette A. Pomenya,Ewan E. Smith,Roanne Denton,Paul R. Jenkins,William P. Steward,Karen Brown,Andreas J. Gescher,Stewart Sale +9 more
TL;DR: Results indicate that the 3',4',5'- arrangement of either hydroxy (OH) or methoxy (OMe) residues is important for growth arrest of these cells and that the OMe analogues may be superior to their OH counterparts.
Journal ArticleDOI
Influence of oestradiol and tamoxifen on oestrogen receptors-alpha and -beta protein degradation and non-genomic signalling pathways in uterine and breast carcinoma cells.
Emma Horner-Glister,M Maleki-Dizaji,C J Guerin,Suzanne M. Johnson,Jerry Styles,Ian N.H. White +5 more
TL;DR: The data have demonstrated tamoxifen or oestradiol control of ER subtype stability and that non-genomic activation of transcription pathways is cell specific, and that the alternative Erk signalling pathway is activated in Ishikawa cells following ostradiol treatment in the absence of an active proteasome pathway.
Journal ArticleDOI
Tamoxifen Forms DNA Adducts in Human Colon after Administration of a Single [14C]-Labeled Therapeutic Dose
Karen Brown,Elaine M. Tompkins,David J. Boocock,Elizabeth A. Martin,Peter B. Farmer,Kenneth W. Turteltaub,Esther A. Ubick,David Hemingway,Emma Horner-Glister,Ian N.H. White +9 more
TL;DR: The propensity of tamoxifen to bind irreversibly to colorectal DNA when given to 10 women as a single [(14)C]-labeled therapeutic (20 mg) dose, approximately 18 h before undergoing colon resections is investigated to provide a mechanistic basis through which tamoxIFen could increase the incidence of colon cancers in women.